JPMorgan assumed coverage of Universal Health (UHS) with a Neutral rating and $226 price target The firm believes favorable trends across sales and expenses for managed care companies should allow for margin expansion in 2025, but considers the setup into 2026 to be more bearish, saying potential volume rollover and regulatory uncertainty following the November elections present an “imperfect storm” of payer mix headwinds and a negative overhang on go-forward sentiment for the hospitals.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Netflix, MongoDB downgraded: Wall Street’s top analyst calls
- Universal Health downgraded to Neutral from Buy at Goldman Sachs
- Universal Health price target lowered to $251 from $275 at TD Cowen
- Universal Health price target lowered to $230 from $285 at Wells Fargo
- BofA shakes up ratings of healthcare stocks following Trump win